Nanotherapy for cancer: targeting and multifunctionality in the future of cancer therapies

A Ediriwickrema, WM Saltzman - ACS biomaterials science & …, 2015 - ACS Publications
Cancer continues to be a prevalent and lethal disease, despite advances in tumor biology
research and chemotherapy development. Major obstacles in cancer treatment arise from …

[HTML][HTML] Effects of chemotherapy agents on circulating leukocyte populations: Potential implications for the success of CAR-T cell therapies

NTH Truong, T Gargett, MP Brown, LM Ebert - Cancers, 2021 - mdpi.com
Simple Summary CAR-T cell therapy is a new approach to cancer treatment that is based on
manipulating a patient's own T cells such that they become able to seek and destroy cancer …

Can intracellular drug delivery using hyaluronic acid functionalised pH-sensitive liposomes overcome gemcitabine resistance in pancreatic cancer?

M Tang, D Svirskis, E Leung, M Kanamala… - Journal of controlled …, 2019 - Elsevier
Chemoresistance poses a major challenge in cancer treatment. This study aims to
investigate whether intracellular drug delivery using hyaluronic acid (HA) functionalised pH …

[HTML][HTML] Tumour growth and immune evasion as targets for a new strategy in advanced cancer

A Nicolini, P Ferrari, G Rossi… - Endocrine-Related …, 2018 - erc.bioscientifica.com
It has become clearer that advanced cancer, especially advanced breast cancer, is an
entirely displayed pathological system that is much more complex than previously …

[HTML][HTML] Repurposed drugs in gastric cancer

D Araújo, E Ribeiro, I Amorim, N Vale - Molecules, 2022 - mdpi.com
Gastric cancer (GC) is one of the major causes of death worldwide, ranking as the fifth most
incident cancer in 2020 and the fourth leading cause of cancer mortality. The majority of GC …

Cutting-edge advancements in anticancer drug delivery and scope for theranostics using biocompatible multifunctional mesoporous silica nanoparticles

S Sarnaik, D Bhatane, SR Pamshong… - Journal of Drug Delivery …, 2024 - Elsevier
With the advancement in nanotechnology, treatment of cancer has improved significantly in
the past few decades. However, the hunt for exciting new generation of nanocarriers has no …

Información de Enfermería en Pacientes Oncológicos

J Alfonso Fernández - 2016 - uvadoc.uva.es
La información facilitada a los pacientes y sus familiares en relación a su estado de salud,
desde el punto de vista médico y sobre los cuidados de enfermería tiene una gran …

[PDF][PDF] Lo que el paciente debe saber sobre la quimioterapia (I)

JR Lladós - El farmacéutico: profesión y cultura, 2021 - elfarmaceutico.es
Ya hemos visto en esta sección hasta qué punto la confirmación de un diagnóstico de
cáncer suele generar en el paciente, en mayor o menor grado, una respuesta ansiosa, y …

Auswirkungen von Chemotherapeutika auf zirkulierende Leukozytenpopulationen: Mögliche Implikationen für den Erfolg von CAR-T-Zell-Therapien

NTH Truong, T Gargett, MP Brown, LM Ebert - Kompass Onkologie, 2021 - karger.com
Die CAR-T-Zell-Therapie ist ein neuer Ansatz der Krebsbehandlung, bei dem körpereigene
T-Zellen eines Patienten gentechnisch so verändert werden, dass sie ganz gezielt …

CHEMOTHERAPY AND HORMONAL THERAPY Overview I. Principles of cancer chemotherapy (Wellstein, 2018) A. Cancer chemotherapy remains an integral …

A Howard, C Martin, P Davis - Core Curriculum for Oncology …, 2023 - books.google.com
(3) Cells are ready for division or mitosis. e. Mitosis (M)—the shortest phase of the cell cycle
in which cellular division occurs in five phases: prophase, prometaphase, metaphase …